Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
06 11 2019
Historique:
received: 28 05 2019
accepted: 08 08 2019
pubmed: 21 9 2019
medline: 23 5 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

A majority of US women report past use of vaginal lubricants to enhance the ease and comfort of intimate sexual activities. Lubricants are also administered frequently in clinical practice. We sought to investigate if hyperosmolar lubricants are toxic to the vaginal mucosal epithelia. We tested a panel of commercially available lubricants across a range of osmolalities in human monolayer vaginal epithelial cell (VEC) culture and a robust 3-dimensional (3-D) VEC model. The impact of each lubricant on cellular morphology, cytotoxicity, barrier targets, and the induction of inflammatory mediators was examined. Conceptrol, containing nonoxynol-9, was used as a cytotoxicity control. We observed a loss of intercellular connections, and condensation of chromatin, with increasing lubricant osmolality. EZ Jelly, K-Y Jelly, Astroglide, and Conceptrol induced cytotoxicity in both models at 24 hours. There was a strong positive correlation (r = 0.7326) between lubricant osmolality and cytotoxicity in monolayer VECs, and cell viability was reduced in VECs exposed to all the lubricants tested for 24 hours, except McKesson. Notably, select lubricants altered cell viability, barrier targets, and inflammatory mediators in 3-D VECs. These findings indicate that hyperosmolar lubricants alter VEC morphology and are selectively cytotoxic, inflammatory, and barrier disrupting in the 3-D VEC model.

Sections du résumé

BACKGROUND
A majority of US women report past use of vaginal lubricants to enhance the ease and comfort of intimate sexual activities. Lubricants are also administered frequently in clinical practice. We sought to investigate if hyperosmolar lubricants are toxic to the vaginal mucosal epithelia.
METHODS
We tested a panel of commercially available lubricants across a range of osmolalities in human monolayer vaginal epithelial cell (VEC) culture and a robust 3-dimensional (3-D) VEC model. The impact of each lubricant on cellular morphology, cytotoxicity, barrier targets, and the induction of inflammatory mediators was examined. Conceptrol, containing nonoxynol-9, was used as a cytotoxicity control.
RESULTS
We observed a loss of intercellular connections, and condensation of chromatin, with increasing lubricant osmolality. EZ Jelly, K-Y Jelly, Astroglide, and Conceptrol induced cytotoxicity in both models at 24 hours. There was a strong positive correlation (r = 0.7326) between lubricant osmolality and cytotoxicity in monolayer VECs, and cell viability was reduced in VECs exposed to all the lubricants tested for 24 hours, except McKesson. Notably, select lubricants altered cell viability, barrier targets, and inflammatory mediators in 3-D VECs.
CONCLUSIONS
These findings indicate that hyperosmolar lubricants alter VEC morphology and are selectively cytotoxic, inflammatory, and barrier disrupting in the 3-D VEC model.

Identifiants

pubmed: 31539059
pii: 5563809
doi: 10.1093/infdis/jiz412
pmc: PMC6834067
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Inflammation Mediators 0
Lubricants 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2009-2018

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI119012
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Menopause. 2013 Sep;20(9):888-902; quiz 903-4
pubmed: 23985562
Eur J Obstet Gynecol Reprod Biol. 1992 May 13;44(3):221-7
pubmed: 1607062
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4509-18
pubmed: 17898272
Obstet Gynecol. 2013 Apr;121(4):773-80
pubmed: 23635677
J Assist Reprod Genet. 2014 Mar;31(3):333-9
pubmed: 24390681
J Acquir Immune Defic Syndr. 2005 May 1;39(1):1-8
pubmed: 15851907
J Infect Dis. 2010 Dec 15;202(12):1907-15
pubmed: 21067371
Maturitas. 2013 Aug;75(4):373-9
pubmed: 23731983
J Clin Invest. 2004 Mar;113(6):808-10
pubmed: 15067312
Am J Reprod Immunol. 2011 Feb;65(2):89-98
pubmed: 20678168
Sex Transm Dis. 2007 Jun;34(6):384-8
pubmed: 17065846
J Vis Exp. 2012 Apr 03;(62):null
pubmed: 22491366
Altern Lab Anim. 2011 Sep;39(4):317-37
pubmed: 21942546
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
Sex Transm Dis. 2010 May;37(5):335-9
pubmed: 20429087
MBio. 2013 Aug 06;4(4):null
pubmed: 23919998
Am J Med Sci. 2012 Jan;343(1):2-9
pubmed: 22143133
Sex Transm Infect. 2010 Aug;86(4):297-302
pubmed: 20660593
J Sex Med. 2009 Sep;6(9):2425-33
pubmed: 19627461
AIDS Res Hum Retroviruses. 2013 Nov;29(11):1475-86
pubmed: 23885658
PLoS One. 2012;7(11):e48328
pubmed: 23144863
Infect Dis Obstet Gynecol. 2012;2012:706540
pubmed: 22693410
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Nat Rev Microbiol. 2010 Nov;8(11):791-801
pubmed: 20948552
J Sex Marital Ther. 2010;36(1):49-65
pubmed: 20063237
Viruses. 2016 Nov 09;8(11):
pubmed: 27834891
J Infect Dis. 2016 Aug 15;214 Suppl 1:S6-S13
pubmed: 27449872
Int J STD AIDS. 1993 May-Jun;4(3):165-70
pubmed: 8391856
J Infect Dis. 2007 Mar 1;195(5):703-10
pubmed: 17262713
BJOG. 2015 Jan;122(2):213-8
pubmed: 25316066
Fertil Steril. 1992 May;57(5):1126-8
pubmed: 1315297
AIDS. 1999 Aug 20;13(12):1511-5
pubmed: 10465075
AIDS Res Hum Retroviruses. 2011 Sep;27(9):1019-24
pubmed: 21309617
Hum Reprod Update. 1998 Sep-Oct;4(5):459-64
pubmed: 10027596
Sex Transm Dis. 2008 Jun;35(6):617-23
pubmed: 18418290
Infect Immun. 2005 Jun;73(6):3783-6
pubmed: 15908412
Sex Transm Infect. 2010 Aug;86(4):318-22
pubmed: 20410077
Can J Vet Res. 1986 Apr;50(2):272-4
pubmed: 3756680
Lancet. 2002 Sep 28;360(9338):971-7
pubmed: 12383665
Biol Reprod. 2010 Mar;82(3):617-27
pubmed: 20007410
J Forensic Sci. 2019 Jan;64(1):207-217
pubmed: 29758097
Toxicol Rep. 2017 Dec 16;5:134-140
pubmed: 29854584

Auteurs

Ellen M Wilkinson (EM)

Department of Obstetrics and Gynecology, College of Medicine-Phoenix, University of Arizona.
Department of Biology and Biochemistry, University of Bath, United Kingdom.

Paweł Łaniewski (P)

Department of Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona, Baltimore.

Melissa M Herbst-Kralovetz (MM)

Department of Obstetrics and Gynecology, College of Medicine-Phoenix, University of Arizona.
Department of Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona, Baltimore.

Rebecca M Brotman (RM)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH